Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Skinvisible's Pre-Tax Income for the
three
months ended in Sep. 2024 was $-0.29 Mil. Skinvisible's Revenue for the
three
months ended in Sep. 2024 was $0.01 Mil. Therefore, Skinvisible's pretax margin for the quarter that ended in Sep. 2024 was -5,740.00%.
The historical rank and industry rank for Skinvisible's Pretax Margin % or its related term are showing as below:
SKVI'
s Pretax Margin % Range Over the Past 10 Years
Min: -11910 Med: -830.89 Max: 228.99
Current: -5920
SKVI's Pretax Margin % is ranked worse than 99.47% of 1874
companies
in the Consumer Packaged Goods industry
Industry Median: 4.72
vs SKVI: -5920.00
Skinvisible Pretax Margin % Historical Data
The historical data trend for Skinvisible's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Skinvisible's Pretax Margin %
For the Household & Personal Products subindustry, Skinvisible's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Skinvisible's Pretax Margin % Distribution in the Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Skinvisible's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where Skinvisible's Pretax Margin % falls into.
Skinvisible Pretax Margin % Calculation
Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.
Skinvisible's Pretax Margin for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
Skinvisible Pretax Margin % Related Terms
Thank you for viewing the detailed overview of Skinvisible's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.
Skinvisible Inc is a pharmaceutical research and development company that has developed and patented a polymer delivery system, Invisicare and formulated over forty topical skin products, which it out-licenses globally. Invisicare is a patented polymer delivery system that enhances the delivery of active ingredients for topically applied skin care products. Its patented technology has a formula and process for combining active ingredients with a delivery system that extends the duration of time the product remains on the skin and active. The Company is also exploring new opportunities in large medical markets outside of the dermatology market such as obesity and other potential markets where a topical or transdermal solution would be a viable alternative.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
SKVI has been successfully added to your 